These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16412793)

  • 1. Should we measure routinely the LDL peak particle size?
    Rizzo M; Berneis K
    Int J Cardiol; 2006 Feb; 107(2):166-70. PubMed ID: 16412793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The significance of low-density-lipoproteins size in vascular diseases.
    Rizzo M; Berneis K; Corrado E; Novo S
    Int Angiol; 2006 Mar; 25(1):4-9. PubMed ID: 16520717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Small, dense low-density-lipoproteins and the metabolic syndrome.
    Rizzo M; Berneis K
    Diabetes Metab Res Rev; 2007 Jan; 23(1):14-20. PubMed ID: 17080469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-density lipoprotein size and cardiovascular risk assessment.
    Rizzo M; Berneis K
    QJM; 2006 Jan; 99(1):1-14. PubMed ID: 16371404
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-density lipoprotein size and cardiovascular prevention.
    Rizzo M; Berneis K
    Eur J Intern Med; 2006 Mar; 17(2):77-80. PubMed ID: 16490681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Who needs to care about small, dense low-density lipoproteins?
    Rizzo M; Berneis K
    Int J Clin Pract; 2007 Nov; 61(11):1949-56. PubMed ID: 17935554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men.
    Sjögren P; Fredrikson GN; Rosell M; de Faire U; Hamsten A; Nilsson J; Hellenius ML; Fisher RM
    Metabolism; 2008 Mar; 57(3):362-6. PubMed ID: 18249208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, patho-physiology and therapeutic aspects.
    Lamarche B; Lemieux I; Després JP
    Diabetes Metab; 1999 Sep; 25(3):199-211. PubMed ID: 10499189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cholesteryl ester transfer protein in metabolic syndrome.
    Sandhofer A; Kaser S; Ritsch A; Laimer M; Engl J; Paulweber B; Patsch JR; Ebenbichler CF
    Obesity (Silver Spring); 2006 May; 14(5):812-8. PubMed ID: 16855190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Postprandial hyperlipidemia, small and dense LDL, HDL sub-fractions].
    Braschi S
    Ann Med Interne (Paris); 2001 Apr; 152(3):162-8. PubMed ID: 11431575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study.
    Kathiresan S; Otvos JD; Sullivan LM; Keyes MJ; Schaefer EJ; Wilson PW; D'Agostino RB; Vasan RS; Robins SJ
    Circulation; 2006 Jan; 113(1):20-9. PubMed ID: 16380547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Should we routinely measure low-density and high-density lipoprotein subclasses?
    Rizzo M; Berneis K; Zeljkovic A; Vekic J
    Clin Lab; 2009; 55(11-12):421-9. PubMed ID: 20225664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
    Otvos JD; Collins D; Freedman DS; Shalaurova I; Schaefer EJ; McNamara JR; Bloomfield HE; Robins SJ
    Circulation; 2006 Mar; 113(12):1556-63. PubMed ID: 16534013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Concentration and relative distribution of low-density lipoprotein subfractions in patients with metabolic syndrome defined according to the National Cholesterol Education Program criteria.
    Gazi I; Tsimihodimos V; Filippatos T; Bairaktari E; Tselepis AD; Elisaf M
    Metabolism; 2006 Jul; 55(7):885-91. PubMed ID: 16784959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low density lipoprotein particle size phenotyping in healthy persons and patients with myocardial infarction.
    Alabakovska SB; Labudović DD; Tosheska KN; Todorova BB
    Croat Med J; 2002 Jun; 43(3):290-5. PubMed ID: 12035134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postprandial changes in LDL phenotypes in patients with myocardial infarction.
    Koba S; Tsunoda F; Hirano T; Iso Y; Suzuki H; Geshi E; Katagiri T
    Eur J Clin Invest; 2005 Mar; 35(3):171-9. PubMed ID: 15733071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications?
    Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G
    Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women.
    Tzotzas T; Filippatos TD; Triantos A; Bruckert E; Tselepis AD; Kiortsis DN
    Nutr Metab Cardiovasc Dis; 2008 Sep; 18(7):477-82. PubMed ID: 17928209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Baseline triglyceride levels and insulin sensitivity are major determinants of the increase of LDL particle size and buoyancy induced by rosuvastatin treatment in patients with primary hyperlipidemia.
    Kostapanos MS; Milionis HJ; Lagos KG; Rizos CB; Tselepis AD; Elisaf MS
    Eur J Pharmacol; 2008 Aug; 590(1-3):327-32. PubMed ID: 18585701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small, dense low-density lipoproteins (LDL) are predictors of cardio- and cerebro-vascular events in subjects with the metabolic syndrome.
    Rizzo M; Pernice V; Frasheri A; Di Lorenzo G; Rini GB; Spinas GA; Berneis K
    Clin Endocrinol (Oxf); 2009 Jun; 70(6):870-5. PubMed ID: 18771560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.